These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rapid diagnosis of pseudomosaicism in a case of Level II mosaicism for trisomy 5 in a single colony from an in situ culture of amniocytes and a review of mosaic trisomy 5 at amniocentesis.
    Author: Chen CP, Chang SJ, Chern SR, Wu PS, Chen YN, Chen SW, Yang CW, Pan CW, Wang W.
    Journal: Taiwan J Obstet Gynecol; 2016 Aug; 55(4):602-3. PubMed ID: 27590391.
    Abstract:
    OBJECTIVE: We present prenatal diagnosis of pseudomosaicism for trisomy 5 and a review of the literature of mosaic trisomy 5 at amniocentesis. CASE REPORT: A 39-year-old woman underwent amniocentesis at 17 weeks of gestation, which revealed a karyotype of 47,XY,+5[1]/46,XY[20]. The single colony with trisomy 5 had five metaphase cells, and all five cells had the karyotype of 47,XY,+5. Repeat amniocentesis performed at 20 weeks of gestation revealed a karyotype of 46,XY in 27/27 colonies. Simultaneously, interphase fluorescence in situ hybridization (FISH), array comparative genomic hybridization (aCGH), and quantitative fluorescent polymerase chain reaction (QF-PCR) were performed on uncultured amniocytes. Interphase FISH revealed no trisomy 5 in 100 uncultured amniocytes. aCGH revealed no genomic imbalance. QF-PCR excluded uniparental disomy 5. A healthy 3662-g male baby was delivered with a normal karyotype in cord blood and 3.75% (3/80 cells) of trisomy 5 cells in uncultured urinary cells compared with 0.95% (1/105 cells) of trisomy 5 cells in normal control examined by FISH at 1.5 months of age. A review of seven cases with mosaic trisomy 5 at amniocentesis shows that 4/7 had clinically normal outcome, 3/7 had structural defects, mainly the heart, 6/6 had normal karyotype in blood, and 2/3 had mosaic trisomy 5 in the fetal tissues. CONCLUSION: Prenatal diagnosis of mosaic trisomy 5 should alert the possibility of fetal structural abnormalities, especially the heart, and culture artifacts. We suggest that the application of molecular cytogenetic techniques such as aCGH, interphase FISH, and QF-PCR on uncultured amniocytes is useful in our understanding of the mosaic status at repeat amniocentesis.
    [Abstract] [Full Text] [Related] [New Search]